BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

649 related articles for article (PubMed ID: 23482310)

  • 1. Synthesis and biological evaluation of some novel pyrazolopyrimidines incorporating a benzothiazole ring system.
    Azam MA; Dharanya L; Mehta CC; Sachdeva S
    Acta Pharm; 2013 Mar; 63(1):19-30. PubMed ID: 23482310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of some novel pyrazolo[3,4-d]pyrimidine derivatives as potential antimicrobial agents.
    Holla BS; Mahalinga M; Karthikeyan MS; Akberali PM; Shetty NS
    Bioorg Med Chem; 2006 Mar; 14(6):2040-7. PubMed ID: 16310361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of some novel pyrazolo[3,4-b]pyridine and pyrazolo[3,4-d]pyrimidine derivatives bearing 5,6-diphenyl-1,2,4-triazine moiety as potential antimicrobial agents.
    El-Sayed Ali T
    Eur J Med Chem; 2009 Nov; 44(11):4385-92. PubMed ID: 19586688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, anticancer and radioprotective activities of some new pyrazolo[3,4-d]pyrimidines containing amino acid moieties.
    Ghorab MM; Ragab FA; Noaman E; Heiba HI; Aboulmagd SA
    Arzneimittelforschung; 2009; 59(2):96-103. PubMed ID: 19338140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of some thiazolyl and thiadiazolyl derivatives of 1H-pyrazole as anti-inflammatory antimicrobial agents.
    Bekhit AA; Ashour HM; Abdel Ghany YS; Bekhit Ael-D; Baraka A
    Eur J Med Chem; 2008 Mar; 43(3):456-63. PubMed ID: 17532544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antimicrobial activity of novel pyrazolo[3,4-d]pyrimidin derivatives.
    Khobragade CN; Bodade RG; Konda SG; Dawane BS; Manwar AV
    Eur J Med Chem; 2010 Apr; 45(4):1635-8. PubMed ID: 20096486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antimicrobial activity of some new thiazole, thiophene and pyrazole derivatives containing benzothiazole moiety.
    Bondock S; Fadaly W; Metwally MA
    Eur J Med Chem; 2010 Sep; 45(9):3692-701. PubMed ID: 20605657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anhydrous versus hydrated N4-substituted 1H-pyrazolo[3,4-d]pyrimidine-4,6-diamines: hydrogen bonding in two and three dimensions.
    Trilleras J; Quiroga J; Cobo J; Marchal A; Nogueras M; Low JN; Glidewell C
    Acta Crystallogr B; 2008 Oct; 64(Pt 5):610-22. PubMed ID: 18799849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, antimicrobial and anti-cancer activities of some new N-ethyl, N-benzyl and N-benzoyl-3-indolyl heterocycles.
    El-Sawy ER; Mandour AH; Mahmoud K; Islam IE; Abo-Salem HM
    Acta Pharm; 2012 Jun; 62(2):157-79. PubMed ID: 22750815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of some thio containing pyrrolo [2,3-d]pyrimidine derivatives for their anti-inflammatory and anti-microbial activities.
    Mohamed MS; Kamel R; Fatahala SS
    Eur J Med Chem; 2010 Jul; 45(7):2994-3004. PubMed ID: 20399543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enaminonitrile in heterocyclic synthesis: synthesis and antimicrobial evaluation of some new pyrazole, isoxazole and pyrimidine derivatives incorporating a benzothiazole moiety.
    Bondock S; Fadaly W; Metwally MA
    Eur J Med Chem; 2009 Dec; 44(12):4813-8. PubMed ID: 19683840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antimicrobial activity of some new heterocycles incorporating antipyrine moiety.
    Bondock S; Rabie R; Etman HA; Fadda AA
    Eur J Med Chem; 2008 Oct; 43(10):2122-9. PubMed ID: 18255196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of novel pyrazoles and pyrazolo[3,4-d]pyrimidines incorporating a benzenesulfonamide moiety.
    Ashour HM; Wahab AE
    Arch Pharm (Weinheim); 2009 Apr; 342(4):238-52. PubMed ID: 19340837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of pyrazolo[4',3':5,6]pyrano[2,3-d]pyrimidine derivatives for antiviral evaluation.
    Shamroukh AH; Zaki ME; Morsy EM; Abdel-Motti FM; Abdel-Megeid FM
    Arch Pharm (Weinheim); 2007 May; 340(5):236-43. PubMed ID: 17464958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of some hydroxypyrazole derivatives as anti-inflammatory-antimicrobial agents.
    Bekhit AA; Abdel-Rahman HM; Guemei AA
    Arch Pharm (Weinheim); 2006 Feb; 339(2):81-7. PubMed ID: 16470641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, evaluation and docking of novel pyrazolo pyrimidines as potent p38α MAP kinase inhibitors with improved anti-inflammatory, ulcerogenic and TNF-α inhibitory properties.
    Somakala K; Tariq S; Amir M
    Bioorg Chem; 2019 Jun; 87():550-559. PubMed ID: 30928877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists.
    Baraldi PG; Fruttarolo F; Tabrizi MA; Preti D; Romagnoli R; El-Kashef H; Moorman A; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2003 Mar; 46(7):1229-41. PubMed ID: 12646033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationship studies of pyrazolo[3,4-d]pyrimidine derivatives leading to the discovery of a novel multikinase inhibitor that potently inhibits FLT3 and VEGFR2 and evaluation of its activity against acute myeloid leukemia in vitro and in vivo.
    Yang LL; Li GB; Ma S; Zou C; Zhou S; Sun QZ; Cheng C; Chen X; Wang LJ; Feng S; Li LL; Yang SY
    J Med Chem; 2013 Feb; 56(4):1641-55. PubMed ID: 23362959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of analgesic, anti-inflammatory and ulcerogenic activities of some triazolo- and 2-pyrazolyl-pyrido[2,3-d]-pyrimidines.
    Hafez HN; Abbas HA; El-Gazzar AR
    Acta Pharm; 2008 Dec; 58(4):359-78. PubMed ID: 19103572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrazolo[3,4-d]pyrimidine derivatives as COX-2 selective inhibitors: synthesis and molecular modelling studies.
    Raffa D; Maggio B; Plescia F; Cascioferro S; Raimondi MV; Plescia S; Cusimano MG
    Arch Pharm (Weinheim); 2009 Jun; 342(6):321-6. PubMed ID: 19479756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.